BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18765820)

  • 1. Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin.
    Knight JD; Williamson JA; Miranker AD
    Protein Sci; 2008 Oct; 17(10):1850-6. PubMed ID: 18765820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
    Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
    Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effects of two major secretory granules components, insulin and zinc, on human-IAPP amyloid aggregation and membrane damage.
    Khemtemourian L; Antoniciello F; Sahoo BR; Decossas M; Lecomte S; Ramamoorthy A
    Chem Phys Lipids; 2021 Jul; 237():105083. PubMed ID: 33887213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
    Sellin D; Yan LM; Kapurniotu A; Winter R
    Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid catalysis of diabetic amyloid assembly.
    Knight JD; Miranker AD
    J Mol Biol; 2004 Aug; 341(5):1175-87. PubMed ID: 15321714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition.
    Zhang X; St Clair JR; London E; Raleigh DP
    Biochemistry; 2017 Jan; 56(2):376-390. PubMed ID: 28054763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro.
    Chargé SB; de Koning EJ; Clark A
    Biochemistry; 1995 Nov; 34(44):14588-93. PubMed ID: 7578065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of islet amyloid polypeptide to supported lipid bilayers and amyloid aggregation at the membranes.
    Sasahara K; Morigaki K; Okazaki T; Hamada D
    Biochemistry; 2012 Sep; 51(35):6908-19. PubMed ID: 22876830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane permeabilization by Islet Amyloid Polypeptide.
    Engel MF
    Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.
    Caillon L; Lequin O; Khemtémourian L
    Biochim Biophys Acta; 2013 Sep; 1828(9):2091-8. PubMed ID: 23707907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.
    Brender JR; Lee EL; Hartman K; Wong PT; Ramamoorthy A; Steel DG; Gafni A
    Biophys J; 2011 Feb; 100(3):685-692. PubMed ID: 21281583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interspecies Variation Affects Islet Amyloid Polypeptide Membrane Binding.
    Sanders HM; Chalyavi F; Fields CR; Kostelic MM; Li MH; Raleigh DP; Zanni MT; Marty MT
    J Am Soc Mass Spectrom; 2023 Jun; 34(6):986-990. PubMed ID: 37126782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPE conjugated islet amyloid polypeptide probe for detection of peptide oligomers.
    Tsai HC; Huang CH; Tu LH
    Biophys Chem; 2024 Jan; 304():107129. PubMed ID: 37948788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.
    Wiltzius JJ; Sievers SA; Sawaya MR; Eisenberg D
    Protein Sci; 2009 Jul; 18(7):1521-30. PubMed ID: 19475663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.
    Cao P; Marek P; Noor H; Patsalo V; Tu LH; Wang H; Abedini A; Raleigh DP
    FEBS Lett; 2013 Apr; 587(8):1106-18. PubMed ID: 23380070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes.
    Hebda JA; Saraogi I; Magzoub M; Hamilton AD; Miranker AD
    Chem Biol; 2009 Sep; 16(9):943-50. PubMed ID: 19778722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy.
    Nanga RP; Brender JR; Xu J; Hartman K; Subramanian V; Ramamoorthy A
    J Am Chem Soc; 2009 Jun; 131(23):8252-61. PubMed ID: 19456151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.